BioLine RX LtdNASDAQ:BLRXNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.4313
- TODAY'S CHANGE (%)-0.0137 (-3.0787%)
- Bid / Lots0.4012/ 20
- Ask / Lots0.4446/ 16
- Open / Previous Close0.4300 / 0.4450
- Day Range
- 52 Week Range
- Volume399,540
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BLRX |
|---|---|---|
| 09:32 ET | 8545 | 0.43 |
| 09:33 ET | 100 | 0.4355 |
| 09:39 ET | 470 | 0.437451 |
| 09:48 ET | 100 | 0.4355 |
| 09:50 ET | 18669 | 0.43087 |
| 09:51 ET | 2100 | 0.4295 |
| 09:57 ET | 100 | 0.4385 |
| 10:02 ET | 100 | 0.4385 |
| 10:06 ET | 200 | 0.4385 |
| 10:09 ET | 314 | 0.4301 |
| 10:13 ET | 3600 | 0.4384 |
| 10:20 ET | 250 | 0.4343 |
| 10:24 ET | 100 | 0.4312 |
| 10:26 ET | 100 | 0.4385 |
| 10:29 ET | 3000 | 0.4302 |
| 10:31 ET | 100 | 0.4386 |
| 10:33 ET | 11605 | 0.4386 |
| 10:36 ET | 26013 | 0.4312 |
| 10:42 ET | 100 | 0.4352 |
| 10:47 ET | 137 | 0.4364 |
| 10:56 ET | 6282 | 0.4364 |
| 10:58 ET | 5720 | 0.4424 |
| 11:00 ET | 300 | 0.4397 |
| 11:03 ET | 100 | 0.444 |
| 11:07 ET | 460 | 0.4365 |
| 11:09 ET | 2312 | 0.4365 |
| 11:12 ET | 1000 | 0.4407 |
| 11:14 ET | 300 | 0.444 |
| 11:18 ET | 2300 | 0.4366 |
| 11:20 ET | 340 | 0.4424 |
| 11:21 ET | 100 | 0.444 |
| 11:23 ET | 200 | 0.4401 |
| 11:34 ET | 100 | 0.444 |
| 11:38 ET | 100 | 0.4402 |
| 11:48 ET | 100 | 0.4426 |
| 11:50 ET | 100 | 0.44 |
| 11:52 ET | 1160 | 0.4401 |
| 11:56 ET | 1200 | 0.4402 |
| 11:57 ET | 100 | 0.432 |
| 12:08 ET | 245 | 0.4359 |
| 12:12 ET | 10099 | 0.4296 |
| 12:14 ET | 100 | 0.4395 |
| 12:15 ET | 506 | 0.4356 |
| 12:21 ET | 2240 | 0.4312 |
| 12:26 ET | 200 | 0.439 |
| 12:28 ET | 2240 | 0.435549 |
| 12:32 ET | 250 | 0.4399 |
| 12:33 ET | 100 | 0.4356 |
| 12:37 ET | 100 | 0.432 |
| 12:42 ET | 400 | 0.435 |
| 12:44 ET | 100 | 0.435 |
| 12:46 ET | 1000 | 0.434899 |
| 12:50 ET | 200 | 0.431 |
| 12:51 ET | 4200 | 0.4301 |
| 12:55 ET | 300 | 0.435 |
| 12:57 ET | 400 | 0.4375 |
| 01:00 ET | 300 | 0.4301 |
| 01:06 ET | 3000 | 0.4351 |
| 01:15 ET | 100 | 0.4375 |
| 01:20 ET | 200 | 0.4328 |
| 01:22 ET | 1573 | 0.4302 |
| 01:26 ET | 771 | 0.4314 |
| 01:27 ET | 6000 | 0.4302 |
| 01:31 ET | 100 | 0.437 |
| 01:38 ET | 100 | 0.4303 |
| 01:42 ET | 100 | 0.435 |
| 01:47 ET | 100 | 0.4351 |
| 01:49 ET | 100 | 0.4365 |
| 01:51 ET | 36642 | 0.4435 |
| 01:54 ET | 12350 | 0.445 |
| 01:56 ET | 2800 | 0.445 |
| 01:58 ET | 12000 | 0.4426 |
| 02:00 ET | 11200 | 0.4425 |
| 02:02 ET | 4700 | 0.444 |
| 02:03 ET | 11101 | 0.4433 |
| 02:05 ET | 700 | 0.4446 |
| 02:09 ET | 800 | 0.4449 |
| 02:12 ET | 3300 | 0.4441 |
| 02:14 ET | 6350 | 0.4439 |
| 02:16 ET | 700 | 0.4434 |
| 02:20 ET | 4500 | 0.4446 |
| 02:23 ET | 1572 | 0.4446 |
| 02:25 ET | 600 | 0.4446 |
| 02:27 ET | 200 | 0.4446 |
| 02:32 ET | 100 | 0.44465 |
| 02:36 ET | 400 | 0.4422 |
| 02:38 ET | 300 | 0.4422 |
| 02:41 ET | 100 | 0.4447 |
| 02:43 ET | 10000 | 0.4447 |
| 02:45 ET | 1100 | 0.4446 |
| 02:48 ET | 700 | 0.4434 |
| 02:50 ET | 600 | 0.442201 |
| 02:52 ET | 100 | 0.4422 |
| 02:54 ET | 100 | 0.443 |
| 02:56 ET | 26082 | 0.44 |
| 03:03 ET | 60998 | 0.4391 |
| 03:08 ET | 8578 | 0.4447 |
| 03:10 ET | 300 | 0.4396 |
| 03:14 ET | 5250 | 0.4403 |
| 03:15 ET | 100 | 0.4441 |
| 03:17 ET | 100 | 0.4401 |
| 03:21 ET | 7972 | 0.4424 |
| 03:24 ET | 6300 | 0.4401 |
| 03:26 ET | 2400 | 0.4401 |
| 03:28 ET | 100 | 0.4401 |
| 03:30 ET | 100 | 0.4447 |
| 03:32 ET | 200 | 0.4401 |
| 03:33 ET | 100 | 0.4401 |
| 03:35 ET | 100 | 0.44 |
| 03:37 ET | 700 | 0.44 |
| 03:42 ET | 100 | 0.4447 |
| 03:46 ET | 900 | 0.441 |
| 03:48 ET | 100 | 0.441 |
| 03:53 ET | 4275 | 0.437 |
| 03:55 ET | 537 | 0.4403 |
| 04:00 ET | 5603 | 0.4313 |
Nov 6, 2024
DJ BioLine RX Price Target Maintained With a $21.00/Share by HC Wainwright & Co., from 7:55AM ET on Wednesday Nov 06, 2024 by Dow Jones
7:55AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 5, 2024
Oct 16, 2024
BioLineRx Announces USPTO Allowance of New Composition of Matter Patent on Motixafortide, from 7:00AM ET on Wednesday Oct 16, 2024 by Dow Jones
7:00AM ET on Wednesday Oct 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BioLine RX Ltd | 38.1M | -0.6x | --- |
Marker Therapeutics Inc | 33.8M | -3.2x | --- |
Palatin Technologies Inc | 23.5M | -0.6x | --- |
Lumos Pharma Inc | 37.8M | -1.0x | --- |
Dyadic International Inc | 31.0M | -4.3x | --- |
Lipocine Inc | 28.5M | -3.2x | --- |
Company Information
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Contact Information
- Headquarters
- Modi'in Technology Park 2 HaMa'ayan StreetMODIIN, Israel 7177871
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Aharon Schwartz
- Chief Executive Officer
- Philip Serlin
- Chief Financial Officer
- Mali Zeevi
- Vice President - Development
- Ella Sorani
- Vice President-Clinical & Medical Affairs
- Abi Vainstein-Haras
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $38.1M |
|---|---|
Revenue (TTM) | $11.7M |
Shares Outstanding | 80.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.49 |
EPS | $-0.76 |
Book Value | $0.18 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 3.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -391.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
